VTRS (Viatris) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTRS Viatris Inc VTRS
60 GF Score
Price $16.95
GF Value $11.42
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Viatris Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Viatris  (NAS:VTRS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Viatris Cyclically Adjusted PS Ratio Related Terms


Viatris Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Viatris's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris Cyclically Adjusted PS Ratio Chart

Viatris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.49 0.48 0.57 0.60

Viatris Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.46 0.58 0.63 0.75

VTRS vs NBIX, UTHR, ELAN: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Viatris's Cyclically Adjusted PS Ratio falls into.


VTRS
60GF Score
Viatris Inc VTRS
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viatris Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Viatris's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Viatris's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.234/333.9520*333.9520
=3.234

Current CPI (Jun. 2026) = 333.9520.

Viatris Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.859 241.428 8.104
201612 6.110 241.432 8.451
201703 5.065 243.801 6.938
201706 5.517 244.955 7.521
201709 5.559 246.819 7.521
201712 6.037 246.524 8.178
201803 5.194 249.554 6.951
201806 5.439 251.989 7.208
201809 5.542 252.439 7.332
201812 5.964 251.233 7.928
201903 4.846 254.202 6.366
201906 5.532 256.143 7.212
201909 5.738 256.759 7.463
201912 6.178 256.974 8.029
202003 5.066 258.115 6.554
202006 5.281 257.797 6.841
202009 5.741 260.280 7.366
202012 6.287 260.474 8.061
202103 3.664 264.877 4.620
202106 3.784 271.696 4.651
202109 3.733 274.310 4.545
202112 3.581 278.802 4.289
202203 3.444 287.504 4.000
202206 3.359 296.311 3.786
202209 3.322 296.808 3.738
202212 3.161 296.797 3.557
202303 3.086 301.836 3.414
202306 3.250 305.109 3.557
202309 3.251 307.789 3.527
202312 3.187 306.746 3.470
202403 3.023 312.332 3.232
202406 3.179 314.175 3.379
202409 3.130 315.301 3.315
202412 2.912 315.605 3.081
202503 2.721 319.799 2.841
202506 3.053 322.561 3.161
202509 3.230 324.800 3.321
202512 3.215 324.054 3.313
202603 2.995 330.213 3.029
202606 3.234 333.952 3.234

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Viatris (VTRS) Overvalued in 2026?

Based on GuruFocus' analysis, Viatris stock appears to be overvalued. The current stock price of $16.95 is trading 48.4% above its estimated GF Value™ of $11.42. GuruFocus considers Viatris to be Significantly Overvalued.

Key valuation signals for VTRS:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $11.42 vs. price of $16.95 (48.4% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the VTRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viatris Business Description

Address 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
60GF Score

Get the complete analysis for VTRS

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.95
Price
$11.42
GF Value